Prospector Partners LLC Haemonetics Corp Transaction History

Prospector Partners LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 13, 2021	SELL	$111.01 - $139.48 $9.7 Million - $12.2 Million	-87,405 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$88.75 - $119.95 $221,875 - $299,875	2,500 Added 2.94%	87,405 $10.4 Million
Q3 2020 Nov 13, 2020	BUY	$75.65 - $93.58 $6.42 Million - $7.95 Million	84,905 New	84,905 $7.41 Million
Q2 2018 Aug 14, 2018	SELL	$71.53 - $95.75 $2.47 Million - $3.3 Million	-34,500 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$60.72 - $74.41 $497,904 - $610,162	-8,200 Reduced 19.2%	34,500 $2.52 Million
Q4 2017 Feb 14, 2018	SELL	$44.96 - $58.99 $341,696 - $448,324	-7,600 Reduced 15.11%	42,700 $2.48 Million
Q2 2017 Aug 14, 2017	BUY	N/A	50,300	50,300 $1.99 Million

338

55.6M

383K

45.1K

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $3.77B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

Get notified when there are updates to the investment portfolio of Prospector Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Prospector Partners LLC with notifications on news.